Prostate Clinical Trials
TRIALS CURRENTLY OPEN
USOR 19191
Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer.
Also See STAR Trials – USOR #18103, #19151, #16238, #20248